Ju-Eun Kang - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Frontiers in Pharmacology|January 28, 2021

Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell KillingChan Gyu Lee, TaeEun Kim, Sungyoul Hong, et al.

Nucleic Acids Research|November 24, 2025

CRISPR/Cas12a2 enables ultra-sensitive amplification-free RNA detectionHyowon Jang, Ju-Eun Kang, Hansol Kim, et al.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 2, 2024

Unveiling Cas12j Trans-Cleavage Activity for CRISPR Diagnostics: Application to miRNA Detection in Lung Cancer DiagnosisJu-Eun Kang, Hansol Kim, Young-Hoon Lee, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Frontiers in Pharmacology|January 28, 2021

Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell KillingChan Gyu Lee, TaeEun Kim, Sungyoul Hong, et al.

Nucleic Acids Research|November 24, 2025

CRISPR/Cas12a2 enables ultra-sensitive amplification-free RNA detectionHyowon Jang, Ju-Eun Kang, Hansol Kim, et al.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 2, 2024

Unveiling Cas12j Trans-Cleavage Activity for CRISPR Diagnostics: Application to miRNA Detection in Lung Cancer DiagnosisJu-Eun Kang, Hansol Kim, Young-Hoon Lee, et al.

Pageof 1